Why is JSS a strategic partner for your product development?

The JSS Medical Research COVID-19 Task Force


  • We are an international Canadian-based CRO with extensive experience running clinical trials and have been successful within the current landscape in a wide range of therapeutic areas

  • We are involved in 20+ COVID-19 related projects, including vaccines, ranging from Phase I to IV, for the treatment or prevention of the infectious disease
  • JSS’ global sites cover all major geographical areas- we have performed studies in 56 countries

  • Our clinical operations team has been flexible to adjust quickly and meet the needs of regulatory authorities and physicians during this challenging period
  • JSS has agreements with qualified hospital sites and research centres worldwide, where we have also successfully implemented remote and risk-based monitoring for both COVID-19 and non COVID-19 projects

Our Clients

JSS Medical Research provides comprehensive clinical trial management services, from study design to publication of results, in Phase I-IV clinical trials across a broad range of therapeutic areas to the global pharmaceutical, biotechnology, medical device and nutraceutical industries. Biotechnology companies rely on the company's knowledgeable project teams, and its customer-centric and flexible approach to successfully conduct their critical early phase trials, while pharmaceutical companies can leverage its niche post-marketing service offerings.